Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Anthracycline antitumor agent FCE-23762 metabolites synthesized

May 31, 1996

M-246315: A new thymidylate synthase inhibitor

May 31, 1996

LL-95509 exhibits optimum activity against GARFT

May 31, 1996

Marimastat continues to show clinical efficacy

May 24, 1996

SU-101 interim results announced at ASCO

May 24, 1996

Genzyme Transgenics, NCI to collaborate on idiotypic cancer vaccines

May 24, 1996

Paclitaxel-platinum complex combination effective in clinical trials

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.